Search results
26 cze 2023 · Scleritis has a high association with systemic disease. This activity reviews the evaluation and treatment of scleritis and highlights the role of the interprofessional team in caring for patients with this condition.
25 mar 2024 · Scleritis is a painful, destructive, and potentially blinding inflammatory disorder of the sclera that may also involve the cornea, adjacent episclera, and underlying uveal tract. Scleritis has a striking, highly symptomatic clinical presentation (picture 1) (see 'Clinical features' below).
Scleritis often involves piercing pain in your eye that gets worse with eye movement. It can cause permanent damage and vision loss. Treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. It may be caused by an underlying inflammatory disease, fungus or injury. Scleritis should be treated.
4 lis 2016 · Current methods of treatment include non-steroidal anti-inflammatories, corticosteroids, and immunomodulatory therapy. Even with appropriate treatment a portion of patients will experience vision loss.
7 cze 2024 · Treatment strategies include NSAIDs, systemic glucocorticoids, and, in some cases, immunosuppressive agents or biologics, depending on the severity and underlying cause. Early diagnosis and appropriate management are crucial to prevent potential vision-threatening complications.
Key Points. The hallmark symptom of scleritis is pain; examination of the eye typically reveals ocular redness due to engorged scleral vessels. Classification of scleritis into clinical subtypes...
Treatment for scleritis aims to alleviate symptoms, particularly pain, and prevent vision-threatening complications. As an autoimmune disease, treatment is primarily based on systemic drugs to control the inflammation and prevent vision loss or recurrences.
